Press Release | Association for Accessible Medicines

Bates White Whitepaper - CPI (Medicaid Generics Penalty)

Sep 19, 2017 | Rachel Schwartz

CPI Penalty on Medicaid Generic Drugs Threatens Patient Access to Affordable Medicine

Generic Medicines

Aug 22, 2017 | Erica Klinger

Poll: Majority of Californians are Unwilling to Support Proposed Drug Pricing Law

Lab - Pharmaceutical Approval

Aug 3, 2017 | Erica Klinger

AAM Statement on Senate Passage of FDA User Fee Reauthorization (FDARA)

Bill H.R. 2430

Aug 1, 2017 | Erica Klinger

Statement on Timing of FDA User Fee Reauthorization (FDARA)

Jul 18, 2017 | Erica Klinger

FDA Meeting: Administering The Hatch-Waxman Amendments

Jul 17, 2017 | Erica Klinger

Kristin Murphy Joins AAM - Michael Brzica Promoted to Vice President

AAM Applauds House Passage of FDA User Fee Reauthorization

Jul 12, 2017 | Erica Klinger

AAM Applauds House Passage of FDA User Fee Reauthorization

Jul 10, 2017 | Erica Klinger

Rachel Sher Joins Association for Accessible Medicines

Federal Injunction to Block Maryland’s Unconstitutional Drug Price Law

Jul 6, 2017 | Erica Klinger

AAM Requests Federal Injunction to Block Maryland’s Unconstitutional Drug Price Law

Woman holding pill

Jun 28, 2017 | Erica Klinger

More Competition, Access to Lower Cost Generic Drugs is a Win for Patients

Blue and White Pills

Apr 27, 2017 | Erica Klinger

Bill to Lower Drug Prices Gains Bipartisan Momentum in the House and Senate

Medicines

Apr 27, 2017 | Erica Klinger

Expediting Approval of Generic Applications and Stopping REMS Abuse Among Top Priorities for Nation’s Leading Patient Advocacy Group